Earnings Data
Report Date
Nov 05, 2026Before Open (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
0.03Last Year’s EPS
0Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
DE:2B30 Q2 2026 Earnings Report
DE:2B30 Upcoming Earnings
Xeris Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
DE:2B30 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:2B30 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 06, 2026 | €7.25 | €6.90 | -4.83% |
May 07, 2026 | €5.22 | €5.33 | +2.22% |
Mar 02, 2026 | €5.56 | €5.49 | -1.35% |
Nov 06, 2025 | €8.47 | €8.46 | -0.12% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Xeris Pharmaceuticals (DE:2B30) report earnings?
Xeris Pharmaceuticals (DE:2B30) is schdueled to report earning on Nov 05, 2026, Before Open (Confirmed).
What is Xeris Pharmaceuticals (DE:2B30) earnings time?
Xeris Pharmaceuticals (DE:2B30) earnings time is at Nov 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Xeris Pharmaceuticals stock?
The P/E ratio of Xeris Pharmaceuticals is N/A.
What is DE:2B30 EPS forecast?
DE:2B30 EPS forecast for the fiscal quarter 2026 (Q3) is 0.03.